Article Text
Abstract
A 60-year-old-woman was transferred to the Neurosurgical Department from a District General Hospital with some weeks of difficulty with walking, change of personality, headaches and poor memory. An initial CT scan (Fig. 1a) revealed an enhancing frontal mass. By the time of transfer, dexamethasone 16 mg daily had been started. Four days after starting dexamethasone, a scan-guided stereotactic biopsy was undertaken, by which time the enhancing mass was only half its original size (Fig. 1b), adjacent frontal lobe oedema was less, and the hydrocephalus affecting the opposite lateral ventricle had largely resolved. The histology was inconclusive. It did not show any evidence of tumour, only T lymphocytes were detectable, and the dense fibrous tissue with lymphoid infiltrate raised the question of a tuberculoma (Fig. 2). Anti-tuberculous therapy was started by the Infectious Disease Service, and phenytoin started as prophylaxis against seizures. Eight days later I was asked to see the
Statistics from Altmetric.com
Other content recommended for you
- Tuberculosis of the central nervous system
- Lymphomatosis cerebri mimicking iatrogenic Creutzfeldt-Jakob disease
- Primary central nervous system lymphoma
- Fulminant diffuse cerebral toxoplasmosis as the first manifestation of HIV infection
- Progressive multifocal leukoencephalopathy in individuals with minimal or occult immunosuppression
- Tuberculous radiculomyelitis presenting as urinary retention in a child with Down’s syndrome
- Paraneoplastic tumefactive demyelination with underlying combined germ cell cancer
- BTS clinical statement for the diagnosis and management of ocular tuberculosis
- Infectious CNS disease as a differential diagnosis in systemic rheumatic diseases: three case reports and a review of the literature
- Symptomatic, radiological and pathological involvement of the hypothalamus in neuromyelitis optica